Details of the Drug Formulaction

General Information of Drug Formulation (ID: F00602)

• Formulation Name: Albendazole 200 mg tablet
• Company: Central Texas Community Health Centers; McKesson

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Albendazole	(DMYZ57N)	Echinococcus granulosus infectious disease		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Saccharin sodium monohydrate	(E00417)	443755	Flavoring agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant